Zepbound

Eli Lilly Zepbound KwikPens
Payers

Lilly study aims to bolster case for long-term Zepbound benefits

As questions remain about the long-term use of GLP-1s, Eli Lilly is offering a new look at how older adults fare on its medication, Zepbound.
Paige Minemyer Aug 27, 2026 1:34pm
The CVS pharmacy logo is displayed on a sign above a CVS Health Corp store in Las Vegas Nevada on February 7 2024
Favicon Fierce Pharma

CVS will cover Eli Lilly obesity products Zepbound and Foundayo

May 28, 2026 11:20am
Ozempic Wegovy

Him & Hers now offers all FDA-approved GLP-1s

Apr 23, 2026 10:43am
vial of Zepbound obesity drug
Favicon Fierce Pharma

Lilly lowers self-pay prices of single-dose Zepbound vials

Dec 1, 2025 8:00am
White House
Favicon Fierce Pharma

Lilly, Novo reach GLP-1 pricing deals with White House

Nov 6, 2025 12:26pm
weight loss scale weigh measure tape obesity overweight
Favicon Fierce Pharma

Novo, Lilly obesity meds 'highly cost-effective': ICER report

Sep 9, 2025 10:30am